Home/Filings/4/0001193125-25-235245
4//SEC Filing

Ma Stephen Hoi 4

Accession 0001193125-25-235245

CIK 0001820190other

Filed

Oct 8, 8:00 PM ET

Accepted

Oct 9, 8:45 AM ET

Size

5.9 KB

Accession

0001193125-25-235245

Insider Transaction Report

Form 4
Period: 2025-10-08
Ma Stephen Hoi
DirectorCFO and COO
Transactions
  • Award

    Incentive Stock Option (right to buy)

    2025-10-08+60,00060,000 total
    Exercise: $17.58Exp: 2035-10-08Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Notwithstanding the preceding sentence, the shares of Common Stock subject to the Option will not be exercisable until such date as the Issuer's outstanding indebtedness under the Senior Secured Promissory Note issued by the Issuer to Oramed Pharmaceuticals, Inc. on September 21, 2023 and the Tranche B Senior Secured Convertible Notes issued by the Issuer to each of Oramed Pharmaceuticals, Inc., Nomis Bay Ltd., 3i LP and BPY Limited, has been repaid in full.

Documents

1 file

Issuer

Scilex Holding Co

CIK 0001820190

Entity typeother

Related Parties

1
  • filerCIK 0001954364

Filing Metadata

Form type
4
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 8:45 AM ET
Size
5.9 KB